Apparent Diffusion Coefficient Measurement of Myelofibrosis in Mouse Tibia

Abstract

The goal of this Co-Clinical Imaging Research Program (CIRP) pre-clinical imaging protocol (PIP) is to provide detailed description of key steps used to achieve a stated level of technical repeatability (precision) embodied in “Claims”, for MRI measurement of apparent diffusion coefficient (ADC) in tibia bone marrow of myelofibrosis mouse models. This pre-clinical imaging procedure document will be referred to as a “profile” and adheres to a PIP MRI template provided in: https://www.protocols.io/workspaces/pre-clinical-imaging-protocols. This profile details procedures for ADC measurement from diffusion weighted imaging (DWI) acquisition and image processing in MF mouse tibia to achieve stated performance claims. Tibia bone marrow composition in MF mouse models has gradation going from proximal to distil ends of the tibia, therefore separate claims are made for volume of interest (VOI) analysis of ADC maps for each of three distinct sections along the length of the tibia (see Figure 1): Section 1 (proximal)º VOI (~4-5mm3) within 9mm of proximal end of tibia Section 2 (transition)º VOI (~0.4-0.5mm3) from 10 to 12mm of proximal end of tibia Section 3 (distil)º VOI (~0.1-0.2mm3) from 13 to 14mm of proximal end of tibia

Claim 1:A measured change in the mean ADC in Section 1 VOI of MF mouse model tibia that exceeds ±0.037µm2/ms indicates a true biological change has occurred in the tibia bone marrow with 95% confidence. Claim 2:A measured change in the mean ADC in Section 2 VOI of MF mouse model tibia that exceeds ±0.087µm2/ms indicates a true biological change has occurred in the tibia bone marrow with 95% confidence Claim 3:A measured change in the mean ADC in Section 3 VOI of MF mouse model tibia that exceeds ±0.030µm2/ms indicates a true biological change has occurred in the tibia bone marrow with 95% confidence